ASSOCIATION OF THE ACE rs4646994 AND rs4341
POLYMORPHISMS WITH THE PROGRESSION
OF CAROTID ATHEROSCLEROSIS IN SLOVENIAN
PATIENTS WITH TYPE 2 DIABETES MELLITUS
Merlo S1, Novák J2,3,4, Tkáčová N2, Nikolajević Starčević J5, Šantl Letonja M6, Makuc J7,
Cokan Vujkovac A7, Letonja J5, Bregar D5, Zorc M5, Rojko M5, Mankoč S5, Kruzliak P8, Petrovič D5
*Corresponding Author: Professor Daniel Petrovič, M.D., Ph.D., Institute of Histology and Embryology, Faculty
of Medicine University Ljubljana, Korytkova 2, SI-1000 Ljubljana, Slovenia. Tel: +386-1-543-7367. Fax: +386-1-
543-7361. E-mail: daniel.petrovic@mf.uni-lj.si
page: 37
|
|
REFERENCES
1. Grundy SM, Brewer HB Jr, Cleeman JI, Smith
SC Jr, Lenfant C. Definition of metabolic syndrome:
Report of the National Heart, Lung, and
Blood Institute/American Heart Association conference
on scientific issues related to definition.
Arterioscler Thromb Vasc Biol. 2004; 24(2):
e13-e18.
2. Hopkins PN. Molecular biology of atherosclerosis.
Physiol Rev. 2013; 93(3): 1317-1542.
3. Castellon R, Hamdi HK. Demystifying the ACE
polymorphism: From genetics to biology. Curr
Pharm Des. 2007; 13(12): 1191-1198.
4. Nikolajevic Starcevic J, Santl Letonja M, Praznikar
ZJ, Makuc J, Vujkovac AC, Petrovic D. Polymorphisms
XbaI (rs693) and EcoRI (rs1042031)
of the ApoB gene are associated with carotid
plaques but not with carotid intima-media thickness
in patients with diabetes mellitus type 2.
Vasa. 2014; 43(3): 171-180.
5. Saitou M, Osonoi T, Kawamori R, Katakami
N, Kaneto H, Matsuhisa M, et al. Genetic risk
factors and the anti-atherosclerotic effect of pioglitazone
on carotid atherosclerosis of subjects
with type 2 diabetes ‒ A retrospective study. J
Atheroscler Thromb. 2010; 17(4): 386-394.
6. Bonithon-Kopp C, Ducimetiere P, Touboul PJ,
Feve JM, Billaud E, Courbon D, et al. Plasma
angiotensin-converting enzyme activity and carotid
wall thickening. Circulation. 1994; 89(3):
952-954.
7. He Q, Fan C, Yu M, Wallar G, Zhang ZF, Wang
L, et al. Associations of ACE gene insertion/
deletion polymorphism, ACE activity, and
ACE mRNA expression with hypertension in
a Chinese population. PLoS One. 2013; 8(10):
e75870. doi: 10.1371/journal.pone.0075870.
8. Castellano M, Muiesan ML, Rizzoni D, Beschi M,
Pasini G, Cinelli A, et al. Angiotensin-converting
enzyme I/D polymorphism and arterial wall thickness
in a general population. The Vobarno Study.
Circulation. 1995; 91(11): 2721-2724.
9. Islam MS, Lehtimaki T, Juonala M, Kahonen M,
Hutri-Kahonen N, Kainulainen K, et al. Polymorphism
of the angiotensin-converting enzyme
(ACE) and angiotesinogen (AGT) genes and
their associations with blood pressure and carotid
artery intima media thickness among healthy
Finnish young adults ‒ The Cardiovascular risk
in young Finns study. Atherosclerosis. 2006;
188(2): 316-322.
10. Paternoster L, Martinez-Gonzalez NA, Charleton
R, Chung M, Lewis S, Sudlow CL. Genetic
effects on carotid intima-media thickness: Systematic
assessment and meta-analyses of candidate
gene polymorphisms studied in more than
5000 subjects. Circ Cardiovasc Genet. 2010;
3(1): 15-21.
11. Kogawa K, Nishizawa Y, Hosoi M, Kawagishi
T, Maekawa K, Shoji T, et al. Effect of polymorphism
of apolipoprotein E and angiotensinconverting
enzyme genes on arterial wall thickness.
Diabetes. 1997; 46(4): 682-687.
12. Burdon KP, Langefeld CD, Wagenknecht LE,
Carr JJ, Freedman BI, Herrington D, et al. Association
analysis of genes in the renin-angiotensin
system with subclinical cardiovascular disease
in families with type 2 diabetes mellitus: The
diabetes heart study. Diabet Med. 2006; 23(3):
228-234.
13. Purnamasari D, Widjojo BD, Antono D, Syampurnawati
M. ACE gene polymorphism and
atherosclerotic lesion of carotid artery among
offsprings of type 2 diabetes mellitus. Acta Med
Indones. 2012; 44(2): 128-134.
14. Sticchi E, Romagnuolo I, Sofi F, Pratesi G, Pulli
R, Pratesi C, et al. Association between polymorphisms
of the renin angiotensin system and
carotid stenosis. J Vasc Surg. 2011; 54(2): 467-
473.
15. Zhou YF, Yan H, Hou XP, Miao JL, Zhang J,
Yin QX, et al. Association study of angiotensin
converting enzyme gene polymorphism with
elderly diabetic hypertension and lipids levels.
Lipids Health Dis. 2013; 12(1): 187-191.
|
|
|
|
 |
Number 27
VOL. 27 (2), 2024 |
Number 27
VOL. 27 (1), 2024 |
Number 26
Number 26 VOL. 26(2), 2023 All in one |
Number 26
VOL. 26(2), 2023 |
Number 26
VOL. 26, 2023 Supplement |
Number 26
VOL. 26(1), 2023 |
Number 25
VOL. 25(2), 2022 |
Number 25
VOL. 25 (1), 2022 |
Number 24
VOL. 24(2), 2021 |
Number 24
VOL. 24(1), 2021 |
Number 23
VOL. 23(2), 2020 |
Number 22
VOL. 22(2), 2019 |
Number 22
VOL. 22(1), 2019 |
Number 22
VOL. 22, 2019 Supplement |
Number 21
VOL. 21(2), 2018 |
Number 21
VOL. 21 (1), 2018 |
Number 21
VOL. 21, 2018 Supplement |
Number 20
VOL. 20 (2), 2017 |
Number 20
VOL. 20 (1), 2017 |
Number 19
VOL. 19 (2), 2016 |
Number 19
VOL. 19 (1), 2016 |
Number 18
VOL. 18 (2), 2015 |
Number 18
VOL. 18 (1), 2015 |
Number 17
VOL. 17 (2), 2014 |
Number 17
VOL. 17 (1), 2014 |
Number 16
VOL. 16 (2), 2013 |
Number 16
VOL. 16 (1), 2013 |
Number 15
VOL. 15 (2), 2012 |
Number 15
VOL. 15, 2012 Supplement |
Number 15
Vol. 15 (1), 2012 |
Number 14
14 - Vol. 14 (2), 2011 |
Number 14
The 9th Balkan Congress of Medical Genetics |
Number 14
14 - Vol. 14 (1), 2011 |
Number 13
Vol. 13 (2), 2010 |
Number 13
Vol.13 (1), 2010 |
Number 12
Vol.12 (2), 2009 |
Number 12
Vol.12 (1), 2009 |
Number 11
Vol.11 (2),2008 |
Number 11
Vol.11 (1),2008 |
Number 10
Vol.10 (2), 2007 |
Number 10
10 (1),2007 |
Number 9
1&2, 2006 |
Number 9
3&4, 2006 |
Number 8
1&2, 2005 |
Number 8
3&4, 2004 |
Number 7
1&2, 2004 |
Number 6
3&4, 2003 |
Number 6
1&2, 2003 |
Number 5
3&4, 2002 |
Number 5
1&2, 2002 |
Number 4
Vol.3 (4), 2000 |
Number 4
Vol.2 (4), 1999 |
Number 4
Vol.1 (4), 1998 |
Number 4
3&4, 2001 |
Number 4
1&2, 2001 |
Number 3
Vol.3 (3), 2000 |
Number 3
Vol.2 (3), 1999 |
Number 3
Vol.1 (3), 1998 |
Number 2
Vol.3(2), 2000 |
Number 2
Vol.1 (2), 1998 |
Number 2
Vol.2 (2), 1999 |
Number 1
Vol.3 (1), 2000 |
Number 1
Vol.2 (1), 1999 |
Number 1
Vol.1 (1), 1998 |
|
|
